Literature DB >> 28895491

Preliminary Validation of the World Health Organization Disability Assessment Schedule 2.0 for Mild Traumatic Brain Injury.

Deborah L Snell1, Grant L Iverson2, William J Panenka3, Noah D Silverberg4.   

Abstract

The purpose of this study is to examine the reliability, factor structure, and validity of the World Health Organization Disability Assessment Schedule (WHODAS 2.0 12 item version) in a sample of patients who were slow to recover from a mild traumatic brain injury (mTBI). Participants were 79 adults with mTBI recruited from one of four specialty outpatient clinics in Vancouver, Canada. The WHODAS 2.0 12 item version is a disease-nonspecific measure of disability representing six International Classification of Disability, Functioning, and Health activity and participation domains including cognition, mobility, self-care, interpersonal functioning, life activities, and participation. Results of analyses showed that the WHODAS 2.0 had high internal consistency and adequate construct and concurrent validity. A three factor structure emerged in this sample. The scale differentiated between patients with good and those with poor outcomes based on post-concussion syndrome, psychiatric, and pain status. Participants with multiple comorbidities reported the most disability on the WHODAS. Concurrent validity was also supported by lower WHODAS scores in participants who had returned to work versus those who had not. To our knowledge, this is the first study to evaluate the psychometric properties of the WHODAS 2.0 in a sample of people with mTBI. In summary, the WHODAS was sensitive to post-concussion syndrome after mTBI, as well as to health conditions that commonly co-occur with mTBI (e.g., mental health problems and chronic pain).

Entities:  

Keywords:  12 item WHODAS 2.0; mTBI; outcome measures

Mesh:

Year:  2017        PMID: 28895491     DOI: 10.1089/neu.2017.5234

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

1.  Psychological assessment of individuals with Mal de Débarquement Syndrome.

Authors:  Jeff Riley; Diamond Gleghorn; Benjamin C Doudican; Yoon-Hee Cha
Journal:  J Neurol       Date:  2021-09-19       Impact factor: 4.849

2.  Effectiveness of a guideline implementation tool for supporting management of mental health complications after mild traumatic brain injury in primary care: protocol for a randomised controlled trial.

Authors:  Noah D Silverberg; Thalia Otamendi; Penelope Ma Brasher; Jeffrey R Brubacher; Linda C Li; Pierre-Paul Lizotte; William J Panenka; Frank X Scheuermeyer; Patrick Archambault
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

3.  Workplace and non-workplace mild traumatic brain injuries in an outpatient clinic sample: A case-control study.

Authors:  Douglas P Terry; Grant L Iverson; William Panenka; Angela Colantonio; Noah D Silverberg
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

4.  A Live Video Mind-Body Treatment to Prevent Persistent Symptoms Following Mild Traumatic Brain Injury: Protocol for a Mixed Methods Study.

Authors:  Jonathan Greenberg; Tanya Singh; Grant L Iverson; Noah D Silverberg; Eric A Macklin; Robert A Parker; Joseph T Giacino; Gloria Y Yeh; Ana-Maria Vranceanu
Journal:  JMIR Res Protoc       Date:  2021-01-14

5.  Outcomes of a brief coping skills group intervention for adults with severe postconcussion symptoms.

Authors:  Jordan I Ali; Patricia Mahoney; Derry Dance; Noah D Silverberg
Journal:  Concussion       Date:  2019-11-21

6.  Promoting early treatment for mild traumatic brain injury in primary care with a guideline implementation tool: a pilot cluster randomised trial.

Authors:  Noah D Silverberg; William J Panenka; Pierre-Paul Lizotte; Mark T Bayley; Derry Dance; Linda C Li
Journal:  BMJ Open       Date:  2020-10-20       Impact factor: 2.692

7.  Psychometric properties and validation of the polish version of the 12-item WHODAS 2.0.

Authors:  Agnieszka Ćwirlej-Sozańska; Bernard Sozański; Hubert Kotarski; Anna Wilmowska-Pietruszyńska; Agnieszka Wiśniowska-Szurlej
Journal:  BMC Public Health       Date:  2020-08-05       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.